Breadcrumbs Navigation

Home > News & Publications > News and Communications > News

Latest Health News from Duke Medicine News and Communications

Duke Scientists Identify Method of Action for Common Chemotherapy Drugs

A study by scientists at Duke Health is providing insight into how certain commonly-used chemotherapy drugs work, potentially opening new ways to enhance the benefits of treatment for cancer patients.

Duke Health Team Performs First Hand Transplant in North Carolina

A Duke Health team has performed the first hand transplant in North Carolina, attaching the limb to a 54-year-old patient from Laredo, Texas, whose hand was severed in a childhood accident.

Study of 81,000 Adults Examines Mental Illness, Gun Violence and Suicide

People with serious mental illnesses who use guns to commit suicide are often legally eligible to purchase guns, despite having a past record of an involuntary mental health examination and brief hospitalization, according to a new Duke Health analysis.

Duke’s Poliovirus Therapy Shows Survival Benefit in Early Patients

An early group of patients who received a modified form of the poliovirus to treat recurrent glioblastoma brain tumors showed survival improvement over historical controls, according to researchers at the Preston Robert Tisch Brain Tumor Center at Duke Health.

Cancer Patients with ACA Policies Swiftly Reach Out-of-Pocket Caps

A hypothetical leukemia patient buying the life-extending drug therapy for his condition would reach his annual out-of-pocket maximum in a month on most of the bronze policies and half of the silver policies offered through the Affordable Care Act marketplace.

Duke Among Sites to Train First Responders On Infectious Disease Safety

Duke Health is one of eight sites nationally selected to participate in a program to help train first responders and other workers in properly handling infectious disease emergencies.

Scientists Block Breast Cancer Cells From Hiding in Bones

Scientists at the Duke Cancer Institute have identified a molecular key that breast cancer cells use to invade bone marrow in mice, where they may be protected from chemotherapy or hormonal therapies that could otherwise eradicate them.

Duke’s Poliovirus Therapy Wins “Breakthrough” Status to Expedite Research

The recombinant poliovirus therapy developed at the Preston Robert Tisch Brain Tumor Center at Duke Health has been granted “breakthrough therapy designation” from the U.S. Food and Drug Administration.

Bioengineered Blood Vessel Appears Safe for Dialysis Patients

Man-made blood vessels developed by researchers at Duke University, Yale University and the tissue engineering company Humacyte appear to be both safe and more durable than commonly used synthetic versions in patients undergoing kidney dialysis, the researchers report.

Mouse Model of Autism Offers Insights to Human Patients, Potential Drug Targets

A new mouse model of a genetically-linked type of autism reveals more about the role of genes in the disorder and the underlying brain changes associated with autism’s social and learning problems.

Page of 27 Next 10 »